Reciprocal alterations of enzymic phenotype of purine and pyrimidine metabolism in induced differentiation of leukemia cells.
Yamaji
Y
Y
First Department of Internal Medicine, Kagawa Medical School, Japan.
Shiotani
T
T
Nakamura
H
H
Hata
Y
Y
Hashimoto
Y
Y
Nagai
M
M
Fujita
J
J
Takahara
J
J
D002453:Cell Cycle; D002454:Cell Differentiation; D002460:Cell Line; D004121:Dimethyl Sulfoxide / Q000494:pharmacology; D050899:GMP Reductase; D006801:Humans; D007168:IMP Dehydrogenase / Q000378:metabolism; D015473:Leukemia, Promyelocytic, Acute; D009247:NADH, NADPH Oxidoreductases / Q000378:metabolism; D010641:Phenotype; D011687:Purines / Q000378:metabolism*; D011743:Pyrimidines / Q000378:metabolism*; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D013936:Thymidine / Q000378:metabolism; D014212:Tretinoin / Q000494:pharmacology; D014407:Tumor Cells, Cultured
D011687:Purines; D011743:Pyrimidines; D014212:Tretinoin; D007168:IMP Dehydrogenase; D009247:NADH, NADPH Oxidoreductases; D050899:GMP Reductase; D013755:Tetradecanoylphorbol Acetate; D013936:Thymidine; D004121:Dimethyl Sulfoxide